The interplay between cardiovascular complications and diabetes presents a significant challenge in patient management. Chronic hyperglycemia, insulin resistance, and dyslipidemia contribute to atherosclerosis, increasing the risk of heart attacks and strokes. Emerging evidence supports the cardioprotective effects of GLP-1 receptor agonists and SGLT2 inhibitors, offering benefits beyond glucose control. Continuous monitoring of blood pressure, lipid profiles, and inflammatory markers is essential for early intervention. Lifestyle modifications, such as dietary adjustments and structured exercise programs, complement pharmacological strategies in reducing cardiovascular risk. Advances in precision cardiology and personalized treatments are paving the way for improved long-term outcomes in diabetic patients.
Mahir Khalil Ibrahim Jallo
Gulf Medical University, Canada
Yong Xiao Wang
Albany Medical College, United States
F Buck Willis
Belize Bible College, Belize
Sujith Rajan
NYU Long Island School of Medicine, United States
Amy Gutman
AdventHealth; Tough Love MD, United States
Paraskevi Theofilou
Hellenic Open University, Greece
Teji S Dhami
Boost your Health and Wellness, United StatesSubmit your abstract Today
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, Belize Bible College, Belize
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Bridging the gap: Coaching patients on GLP-1s for sustainable outcomes beyond the prescription
Keith Hersey, Master Your GLP-1, United States